Article
Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic.
Sexually transmitted infections - 31 May 2024
Goldstein Emily, Moss Elizabeth, Bennett-Slater Susan, Ferguson Lynne, McInally Carol, McHugh Martin, Maxwell Alexandra, Winter Andrew, Gunson Rory N
Abstract excerpt
OBJECTIVES: Antibiotic resistance in gonorrhoea is of significant public health concern with the emergence of resistance to last-line therapies such as ceftriaxone. Despite around half of Neisseria gonorrhoeae isolates tested in the UK being susceptible to ciprofloxacin, very little ciprofloxacin is used in clinical practice. Testing for the S91F mutation associated with ciprofloxacin resistance is now available...
Topics
Join the communities discussing this publication.